Stoke Therapeutics Adds Veteran Leader to Board, R&D Oversight
at www.tipranks.com (Tue, 7-Apr 4:37 PM)
Stoke Therapeutics Accelerates Phase 3 EMPEROR Study Timeline, Targets 2027 for Zorevunersen NDA Submission
Market Chameleon (Mon, 12-Jan 8:16 AM)
